
Clinerion, now part of Citeline, a Norstella company, accelerates clinical research & medical access to treatments for patients. #rwd #clinicaltrials #aiml
- Tweets1.4K
- Following1.1K
- Followers584
- Likes2.2K

ALT The paper analyses oncology metrics from the RWD in the platform’s global, federated EHR network and compares them to WHO-reported statistics through the Global Cancer Observatory. Patient cohort analytics can also be developed using Patient Network Explorer to illustrate most-common co-morbidities, medications, treatments and procedures for a target disease population. The white paper illustrates how Patient Network Explorer’s RWD matches global disease incidence statistics, allowing study of specific patient cohorts to understand contributing diseases, standards of care, drug regiments and outcomes based research across sites in Clinerion’s network.























